Anaphylaxis due to methylprednisolone.
Moreno Escobosa
M C
MC
Department ofAllergology, Hospital Torrecárdenas, Almería, Spain. moreno.escobosa@terra.es
Cruz Granados
S
S
Moya Quesada
M C
MC
Amat López
J
J
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003888:Desensitization, Immunologic / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000503:physiopathology; D004417:Dyspnea; D004890:Erythema; D005260:Female; D006801:Humans; D007114:Immunization; D007273:Injections, Intramuscular; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage / Q000009:adverse effects*; D011058:Pollen / Q000276:immunology*; D011537:Pruritus; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications* / Q000628:therapy
D000893:Anti-Inflammatory Agents; D008776:Methylprednisolone Hemisuccinate